Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

GDTC CytoMed Therapeutics Limited Ordinary Shares
$1.86 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy GDTC stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 22.3M
Enterprise value 14.8M
Forward PE -12.533333
PEG Ratio -12.533333
Enterprise to EBITDA -6.102
Enterprise to revenue 26.587
Price to book MRQ 3.0371566
Price to sales TTM 30.223501

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2024-12-31
Revenue (TTM) 558.2K
EBITDA -2432105
Diluted EPS TTM -0.24
Total Cash (MRQ) 2.2M
Current ratio (MRQ) 5.807
Operating Cash Flow (TTM) -2411618

GDTC trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent GDTC News

Trade, Swap & Stake Crypto on Uphold

Buy, sell, and swap crypto. Stake crypto, earn rewards and securely manage 300+ assets—all in one trusted platform. Terms apply. Capital at risk.

Get Started

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.